Saudi-Born Breakthrough Sets the Stage for the USA's First Robotic Heart Transplant
The Saudi-led procedure, conducted by a multidisciplinary team under the leadership of Professor Feras Khaliel, was the world's first fully robotic heart transplant. It was successfully performed on a 16-year-old patient with end-stage heart failure using a minimally invasive, chest-sparing technique. This novel approach, later patented by Professor Khaliel, significantly reduces infection risk and accelerates patient recovery—an especially critical advancement for immunosuppressed transplant recipients. The technique has since been applied at KFSHRC across both adult and pediatric cases.
Professor Khaliel is now leading efforts to train institutions across the U.S. and Europe in this surgical innovation, with a focus on expanding clinical research and establishing new global standards for robotic complex and innovative procedures.
The American surgical team's adoption of the method pioneered at KFSHRC signals international recognition of Saudi Arabia's leadership in high-impact medical innovation. It also underscores the growing global influence of the Kingdom in shaping the future of healthcare delivery.
In recognition of this medical breakthrough, Professor Khaliel and the leadership team at KFSHRC were honored by His Royal Highness the Saudi Crown Prince and Prime Minister Mohammed bin Salman. The procedure has garnered international acclaim and widespread media attention, positioning it as a defining advancement in the field of heart transplantation.
Importantly, this is not an isolated success. The Riyadh-based innovation has sparked a series of medical advancements and contributed to a broader shift in global clinical practice. As such, Saudi Arabia's healthcare sector is increasingly viewed not only as a regional leader but as a source of transformative models for medical care worldwide.
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Gulf Today
4 hours ago
- Gulf Today
Doctors alarmed at rising meningitis cases in Gaza's children
In a ward of Nasser hospital in southern Gaza a woman is comforting her crying, 16-month-old granddaughter, one of those affected by what aid workers say is a surge of meningitis cases among the Palestinian territory's children. "Sham's temperature suddenly spiked and she became stiff," said the grandmother, Umm Yasmin. "We couldn't find a car to carry her ... She was about to die." The World Health Organization and medical charity Médecins Sans Frontières warn that conditions in Gaza after 21 months of war between Israel and Hamas have increased the risks of meningitis spreading, though they lack clear comparative data to measure the severity of recent outbreaks. "There's been a rise in meningitis cases in children," said Dr Rik Peeperkorn, WHO representative in the Occupied Palestinian Territory. "We are very concerned." Typically, there is a seasonal increase in viral meningitis cases in Gaza between June and August, but the WHO is investigating the role of additional factors such as poor sanitation, limited access to healthcare, and disruption of routine vaccinations. A child is loaded into an ambulance at Al-Nasser hospital in Khan Yunis. AFP Those hospitals still operating are overwhelmed, with beds full and severe shortages of vital antibiotics. "There is no space in the hospitals," Dr Mohammed Abu Mughaisib, deputy medical coordinator for MSF in Gaza. "There is no space to isolate." Airborne and life-threatening bacterial meningitis can spread in overcrowded tents, according to the WHO. Viral meningitis, though less serious, often spreads through the fecal-oral route, meaning it can easily spread in shelters with poor sanitation, the WHO says. Sham's temperature suddenly spiked and she became stiff. We couldn't find a car to carry her... She was about to die. Share Umm Yasmin, grandmother At the Nasser hospital in Khan Younis, Dr Ahmad al-Farra, head of the Paediatrics and Maternity Department, reported nearly 40 cases of newly admitted viral and bacterial meningitis in the last week. In Gaza City to the north, the Paediatrics Department at the Rantisi Children's Hospital has recorded hundreds of cases in recent weeks, according to a report published by the United Nations Office for the Coordination of Humanitarian Affairs. Abu Mughaisib said a lack of lab tests and blood cultures that can help identify the bacteria causing infections was hampering diagnoses. Nearly all Gaza's population of more than 2 million has been displaced by the war, which began in October 2023 when Hamas-led fighters stormed into Israel, killing 1,200 people and taking 251 hostages, according to Israeli tallies. Palestinian children sit at the Nasser hospital in Khan Yunis. AFP Israel's retaliatory military campaign has killed more than 57,000 Palestinians, according to Gaza's health authorities, triggered a hunger crisis, and left much of the territory in ruins. More than 80% of Gaza is now an Israeli-militarized zone or subject to displacement orders, according to the United Nations. Umm Yasmin said her daughter had contracted meningitis for the second time since being displaced. "The tents that we live in ... animals cannot live in them," she said. Doctors warn that vitamin deficiencies and weakened immunity- resulting from limited access to fresh vegetables and protein-are increasing children's vulnerability. The destruction of the sewage system and dirty water caused meningitis to spread, said Nasser hospital's Farra. On May 19, Israel lifted an 11-week aid blockade on Gaza, but assistance since then has been limited. Supplies have been channelled through a controversial U.S.-and Israeli-backed group, bypassing the UN-led system. The WHO has called for more antibiotics to be allowed into the enclave to treat patients. Reuters
Zawya
5 hours ago
- Zawya
Environment Fund signs research agreements with Saudi research institutions to advance environmental innovation
Saudi Arabia's Environment Fund signs research agreements with Saudi research institutions to fund studies on afforestation, water reuse, greywater treatment, seed banking, and coral reef restoration. The agreements reflect the Fund's commitment to fostering applied environmental research and innovation in alignment with Saudi Vision 2030. Riyadh, Saudi Arabia: Saudi Arabia's Environment Fund has signed collaborative research agreements with leading Saudi research institutions to support environmental research across various themes including sustainable plant production, wastewater reuse, greywater treatment, coral regeneration, seed bank development, and nanotechnology applications. This initiative underscores the Fund's commitment to positioning Saudi Arabia as a regional leader in environmental innovation and contributes to the Kingdom's long term sustainability agenda under Vision 2030. Further, these research collaborations are also designed to bridge academic expertise with national environmental priorities, supporting practical solutions that enhance climate resilience, biodiversity conservation, and natural resource sustainability. Speaking of the agreements with the research institutions, 'These agreements position Saudi Arabia at the forefront of scientific and environmental innovation. By nurturing academic talent and promoting environmental research more widely, we are building localized capacity to develop impactful solutions relevant to Saudi Arabia and able to respond to global concerns,' said Munir bin Fahad Al-Sahli, CEO of the Environment Fund. Among the institutions with which the Environment Fund has finalized research agreements are Tabuk University, University of Jeddah, Northern Border University, King Saud University, and Imam Mohammad Ibn Saud Islamic University. These institutions will conduct research in areas such as seed banking and plant conservation, solar-powered water recovery, coral regeneration, greywater treatment using biotechnological methods, environmental nanocomposites, afforestation, and agrivoltaics. Additional agreements with other institutions are currently under review or pending approval. A notable project is a partnership with the Coral Research & Development Accelerator Platform (CORDAP) to support the development of a smart-decision framework for coral restoration. The project applies advanced physiological screening and long-term monitoring to identify heat-resilient coral colonies, contributing to more effective restoration outcomes and supporting marine biodiversity in the face of climate change. The Environment Fund continues to strengthen its collaboration with academic and research institutions as part of its broader strategy to enhance environmental knowledge, foster innovation, and support the national green transition in line with Vision 2030.
Al Etihad
7 hours ago
- Al Etihad
Abu Dhabi leads high-level delegation to US, showcasing emirate's global leadership in healthcare innovation
8 July 2025 13:10 ABU DHABI (ALETIHAD)Department of Health – Abu Dhabi (DoH) has led a high-level delegation on a strategic mission to the US to strengthen partnerships and showcase Abu Dhabi's excellence in life sciences and precision visit reflected the emirate's global leadership in healthcare innovation and its commitment to international cooperation to advance scientific research, innovation, and ethical medical delegation visited key US cities including Boston, Washington DC, and Philadelphia, in parallel with Abu Dhabi's participation at BIO International Convention 2025, one of the world's foremost biotechnology visit spotlighted the emirate's achievements in AI, digital health, genomics, and clinical research, and showcased Abu Dhabi's Health, Endurance, Longevity and Medicine (HELM) Life Science Cluster, while promoting long-term strategic partnerships with government entities, research institutions, and global Excellency Dr Noura Khamis Al Ghaithi, Undersecretary of DoH, said: 'This mission demonstrated Abu Dhabi's ongoing efforts to cement its position as a global centre of excellence in health and life sciences. We are committed to fostering partnerships that advance healthcare innovation and enhance quality of life, both in the UAE and globally.'The delegation conducted more than 20 strategic meetings and visits with public and private sector leaders across the US, aimed at enhancing knowledge exchange and investment opportunities, and marked the signing of new agreements that will accelerate the adoption of advanced health mission facilitated joint actions between DoH and global organisations set to shape the future of healthcare. These alliances reinforce the Emirate's steadfast dedication to advancing health outcomes through impactful global collaborations, pioneering research and a robust infrastructure that fosters innovation, talent and investment. Key agreements and partnerships were formed with prestigious US-based peers and partners, including the University of California, San Francisco, the Innovative Genomics Institute, Sanofi, Boehringer Ingelheim, Abbott, Aetna International, GEMMABio and Children's National Hospital. These collaborations focus on establishing genome surgery centres, advancing vaccine development and manufacturing, integrating innovative research platforms and localising pharmaceutical production, while also expanding access to US healthcare networks, developing genomics and biotechnology research centres and launching advanced cell and gene therapy programmes for the side-lines of Abu Dhabi's participation at BIO International Convention in Boston, USA, the Department of Health – Abu Dhabi, in collaboration with Johnson & Johnson (J&J) and Sheikh Shakhbout Medical City (SSMC), a flagship hospital in the UAE for serious and complex care and a subsidiary of the PureHealth group, have successfully enabled expedited access to Tremfya®, a next-generation biologic medication for patients with Inflammatory Bowel Disease (IBD). This strategic partnership marks the first availability of the treatment outside the United States, reinforcing Abu Dhabi's position as a as a pioneering destination for healthcare innovation and advanced, patient-focused Abu Dhabi's innovation ecosystem, the delegation included key stakeholders such as Abu Dhabi Investment Office, Mubadala BIO, M42, Masdar City, KEZAD Group, PureHealth, StartAD, Khalifa University, New York University Abu Dhabi, and Etihad Dhabi continues to lead the region in genomics through the Emirati Genome Programme, which has successfully sequenced more than 800,000 samples, creating one of the most advanced national genomic databases. The emirate is also home to more than 90 licensed research centres and over 30 ongoing clinical trials in areas such as oncology, rare diseases, and chronic data platforms such as Malaffi, which securely store over 5 million patient records—enable AI-powered insights and real-world evidence, while national initiatives like the Golden Visa have enabled more than 2,000 long-term visas for researchers and healthcare professionals from around the world. This strategic visit reflected Abu Dhabi's broader vision for healthcare transformation—driven by innovation, investment, and a deep commitment to global collaboration.
